Loading…

High serum miR-421 is associated with metabolic dysregulation and inflammation in patients with metabolic syndrome

To explore the association of circulating miRNAs with adiposity, metabolic status and inflammatory biomarkers in patients with metabolic syndrome (MetS). Serum levels of 372 miRNAs were measured in patients with (n = 6) and without MetS (n = 6) by quantitative PCR array, and dysregulated miRNAs were...

Full description

Saved in:
Bibliographic Details
Published in:Epigenomics 2021-03, Vol.13 (6), p.423-436
Main Authors: Braga, Aécio A, Bortolin, Raul H, Graciano-Saldarriaga, Magda E, Hirata, Thiago Dc, Cerda, Alvaro, de Freitas, Renata Cc, Lin-Wang, Hui T, Borges, Jessica B, França, João Id, Masi, Laureane N, Curi, Rui, Pithon-Curi, Tania C, Sampaio, Marcelo F, Castro, Lara R, Bastos, Gisele M, Hirata, Rosario Dc, Hirata, Mario H
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:To explore the association of circulating miRNAs with adiposity, metabolic status and inflammatory biomarkers in patients with metabolic syndrome (MetS). Serum levels of 372 miRNAs were measured in patients with (n = 6) and without MetS (n = 6) by quantitative PCR array, and dysregulated miRNAs were validated in a larger cohort (MetS, n = 89; non-MetS, n = 144). In the screening study, seven miRNAs were dysregulated in patients with MetS, and miR-421 remained increased in the validation study. miR-421 was associated with a high risk of MetS and insulin resistance and hypertension and correlated with glycated hemoglobin, triacylglycerols, high-sensitivity CRP, IL-6, resistin and adiponectin (p 
ISSN:1750-1911
1750-192X
DOI:10.2217/epi-2020-0247